A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/03/2009	WO2009144699A1 Methods of treating cancer of the central nervous system
12/03/2009	WO2009144632A1 Novel compounds
12/03/2009	WO2009144588A2 Riboswitches
12/03/2009	WO2009144584A1 Anti-ligands molecules and biological applications
12/03/2009	WO2009144555A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/03/2009	WO2009144554A1 Pyrazolospiroketone acetyl-c0a carboxylase inhibitors
12/03/2009	WO2009144551A2 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood
12/03/2009	WO2009144550A2 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
12/03/2009	WO2009144527A1 A new metformin glycinate salt for blood glucose control
12/03/2009	WO2009144514A2 Cooperative induction of apoptosis of prostate tissue - prostate cancer prevention - new practice of peripheral androgenic exclusion construction of complex tablet
12/03/2009	WO2009144511A1 Treatment of ringworm
12/03/2009	WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009	WO2009144483A1 Use of zolpidem for cognitive enhancement
12/03/2009	WO2009144467A1 Composition comprising 1, 3 /1, 6 beta glucan for reducing weight
12/03/2009	WO2009144450A1 Tetrahydrofuro [3, 2-b] pyrrol-3-one derivatives as inhibitors of cysteine proteases
12/03/2009	WO2009144432A1 Mc4-r agonists for the treatment of obesity
12/03/2009	WO2009144407A1 Salts of 2-substituted quinolines
12/03/2009	WO2009144395A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009	WO2009144394A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2- α] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009	WO2009144392A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009	WO2009144391A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009	WO2009144365A1 Use of oligonucleotides with modified bases as antiviral agents
12/03/2009	WO2009144286A1 Pharmaceutical compositions comprising brivaracetam
12/03/2009	WO2009144268A1 Composition for increasing gastrointestinal transit time
12/03/2009	WO2009144253A1 Compounds comprising a 3-pyridinol or 5-pyrimidinol ring having an organoseleno or organotelluro substituent for use as antioxidants
12/03/2009	WO2009144240A1 Composition and method for the assay and treatment of anthrax
12/03/2009	WO2009144220A1 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
12/03/2009	WO2009144201A1 Imidazopyridine derivatives as gpr4 receptor modulators
12/03/2009	WO2009144193A1 Micronisable form of salmeterol xinafoate
12/03/2009	WO2009144179A1 L-menthyl-n-(2-hydroxyphenyl)carbamate
12/03/2009	WO2009144137A1 Probiotics to improve gut microbiota
12/03/2009	WO2009144093A1 Hydroxytyrosol benefits mitochondria
12/03/2009	WO2009144009A1 Medical intervention in haematological cancers
12/03/2009	WO2009143992A1 2-alkoxy-substituted dicyanopyridines and use thereof
12/03/2009	WO2009143945A1 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
12/03/2009	WO2009143767A1 Co-crystals of atorvastatin hemi-calcium and butanone, the preparation processes and uses as hmg-coa enzyme inhibitor thereof
12/03/2009	WO2009143763A1 The use of tanshinone iia in preparing medicine for treating obesity and insulin resistance
12/03/2009	WO2009143715A1 Retinoid derivative and pharmaceutical composition and use thereof
12/03/2009	WO2009143714A1 2,4-dihydroxyl chalcone derivative, process for preparing them and use thereof
12/03/2009	WO2009143662A1 Pharmaceutical composition comprising calcium blocker and b family vitamins and the use thereof
12/03/2009	WO2009143619A1 Methods of treating or preventing obesity and obesity-related hypertension
12/03/2009	WO2009143611A1 Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
12/03/2009	WO2009143610A1 Modulating interstitial pressure and oncolytic viral delivery and distribution
12/03/2009	WO2009143578A1 Cancer drug target and methods of diagnosis and therapy
12/03/2009	WO2009143572A1 Methods of treating mammals with eustachian tube dysfunctions
12/03/2009	WO2009143571A1 Antiviral salts
12/03/2009	WO2009143558A1 Injectable formulations
12/03/2009	WO2009129497A3 Methods and compositions for treating age-related macular degeneration
12/03/2009	WO2009129094A3 Combinations of antiviral agents and other compounds
12/03/2009	WO2009126844A3 Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
12/03/2009	WO2009125987A3 Pharmaceutical formulation
12/03/2009	WO2009125975A3 Combination of mitiglinide and metformin and process for preparing same
12/03/2009	WO2009125944A3 Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker
12/03/2009	WO2009125409A3 Fatty acid amides and uses thereof
12/03/2009	WO2009124653A3 Thienopyrimidines
12/03/2009	WO2009124553A3 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
12/03/2009	WO2009124551A3 Use of vanilloid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
12/03/2009	WO2009122045A3 Use of olive oil extract to control skin aging
12/03/2009	WO2009122034A3 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/03/2009	WO2009120717A3 Pyrido [3, 4-b] indoles and methods of use
12/03/2009	WO2009120386A3 Novel solid forms of bendamustine hydrochloride
12/03/2009	WO2009119987A3 Composition comprising pyrazole derivatives for preventing or treating osteoporosis
12/03/2009	WO2009118706A3 The treatment of helminthic infections
12/03/2009	WO2009118657A3 Polymorphic form of an aminoindan mesylate derivative
12/03/2009	WO2009118655A3 Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity
12/03/2009	WO2009118296A3 Novel substituted imidazoquinolines
12/03/2009	WO2009118191A3 Therapy for vitiligo
12/03/2009	WO2009117987A3 Use of boswellia acids and synthetic boswellia acid derivatives for inhibiting microsomal prostanglandin e2 synthase and cathepsin g
12/03/2009	WO2009115572A3 Novel heterocyclic compounds and uses therof
12/03/2009	WO2009114651A8 Use of '-thio-2'-deoxynucleosides as anri orthopoxvirus agents
12/03/2009	WO2009114601A3 Preparation of lenalidomide
12/03/2009	WO2009114088A3 Fullerene therapies for inflammation
12/03/2009	WO2009114087A3 A method for treating pruritus by administering fullerenes
12/03/2009	WO2009114084A3 Method for treating wounds by administering fullerenes
12/03/2009	WO2009113086A3 Ibuprofen liquid fill formulation dosage form and its preparation
12/03/2009	WO2009112703A8 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same
12/03/2009	WO2009110002A4 Novel efflux pump inhibitors
12/03/2009	WO2009109862A3 S100a6 and/or s100a4 inhibitors for treating cancer
12/03/2009	WO2009108657A3 Heteroaryl derivatives as cftr modulators
12/03/2009	WO2009107983A3 Stabilized single-liquid pharmaceutical composition containing docetaxel
12/03/2009	WO2009106599A3 Substituted piperidines as therapeutic compounds
12/03/2009	WO2009105484A3 Anti-infective catheters
12/03/2009	WO2009105265A3 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
12/03/2009	WO2009103476A8 Antitumoral agents with a benzophenanthridine structure and formulations containing them
12/03/2009	WO2009103218A8 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
12/03/2009	WO2009102814A3 Mucosally non-irritative liquid amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis
12/03/2009	WO2009100456A3 Inhibition and treatment of gastrointestinal biofilms
12/03/2009	WO2009100275A3 Compositions and devices
12/03/2009	WO2009100272A3 Effervescent compositions
12/03/2009	WO2009099596A3 Macrocyclic serine protease inhibitors
12/03/2009	WO2009098716A3 Stabilized aqueous formulation containing paracetamol
12/03/2009	WO2009095872A3 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
12/03/2009	WO2009095503A3 Amino acid derivatives used as pharmaceutical substances
12/03/2009	WO2009091856A3 Beta-lactamase inhibitors
12/03/2009	WO2009089260A3 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
12/03/2009	WO2009089147A3 Methods and compositions for the treatment of cancers and pathogenic infections
12/03/2009	WO2009088831A3 Method of inhibiting abcg2 and other treatment methods
12/03/2009	WO2009087286A3 Use of a 1-n-(halo-3-pyridylmethyl)-n-methylamino-1-alkylamino-2-nitroethylene derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites
12/03/2009	WO2009086426A3 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction
12/03/2009	WO2009084021A3 Ophthalmic composition comprising a prostaglandin

1 ... 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 ... 7860